MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
43
Frequently Asked Questions
What is Market Cap of MBX Biosciences Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. MBX Biosciences Inc. market cap is $388.01M.
What is the 52-week high for MBX Biosciences Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. MBX Biosciences Inc. 52 week high is $27.50 as of September 06, 2025.
What is the 52-week low for MBX Biosciences Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. MBX Biosciences Inc. 52 week low is $4.81 as of September 06, 2025.
What is MBX Biosciences Inc. stock price today?
MBX Biosciences Inc. stock price today is $11.55.
What was MBX Biosciences Inc. stock price yesterday?
MBX Biosciences Inc. stock price yesterday was $12.92.
What is the PE ratio of MBX Biosciences Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. MBX Biosciences Inc.’s P/E ratio is -5.01.
What is the Price-to-Book ratio of MBX Biosciences Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. MBX Biosciences Inc. P/B ratio is 1.7697.
What is the 50-day moving average of MBX Biosciences Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. MBX Biosciences Inc. 50-day moving average is $13.12.